FTSE includes Mankind Pharma and Nexus Select Trust in key indices

The Russell, a leading global index provider, announced today the inclusion of Mankind Pharma and Nexus Select Trust in its various equity indices as part of the December Quarterly Review. Mankind Pharma has been added to the FTSE All-World, Large-Cap, Total-Cap, and All-Cap indices, marking a significant recognition for the Indian pharmaceutical company.

Nexus Select Trust also secured its spot in the All-Cap, Small-Cap, and Total-Cap indices. This move reflects the trust’s growing prominence within the financial markets and is expected to increase visibility among investors.

In addition to these two firms, seven other Indian companies have been incorporated into the Total-Cap and Micro-Cap indices. Notably, no Indian stocks were removed from any index during this update cycle, indicating a stable performance by Indian equities in the global market context.

The inclusion of these companies into FTSE’s indices is a testament to their market capitalization growth and liquidity, criteria that are essential for being part of such benchmarks. Investors often use these indices to gauge market performance and as a guide for creating diversified investment portfolios.

The entry of Mankind Pharma into the Large-Cap index is particularly noteworthy as it underscores the company’s position as one of India’s substantial pharmaceutical players with a significant market valuation. For Nexus Select Trust, being listed in both Small-Cap and Total-Cap indices suggests a positive outlook on its growth potential and investment appeal.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.